CSIMarket
 


Kewaunee Scientific Corporation  (NASDAQ: KEQU)
Other Ticker:  
 


Kewaunee Scientific's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics


 
What is Kewaunee Scientific's ROI in the fourth quarter of 2025?
Kewaunee Scientific Corporation achieved a return on average invested assets (ROI) of 9.67 % in its fourth quarter of 2025, this is above KEQU's average return on investment of 4.65%.
Kewaunee Scientific Corporation invested over the 12 months ending in its fourth quarter of 2025 $120 million

ROI fell compared to the third quarter of 2025, despite the net income growth of 257.7% from the third quarter of 2025.

Within the Healthcare sector 86 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 438 to 760.

Definition and Formula of Return on Investment


Return On Investment (Apr 30 2025)
IV. Quarter
(Jan 31 2025)
III. Quarter
(Oct 31 2024)
II. Quarter
(Jul 31 2024)
I. Quarter
(Apr 30 2024)
IV. Quarter
Y / Y Investment Change TTM 38.16 % 30.35 % 16.2 % 14.17 % 11.18 %
Y / Y Net Income Change TTM -39.22 % 98.56 % 194.53 % 420.37 % 1641.96 %
Investment (TTM) in Millions 143 140 99 97 95
Return On Investment (TTM) 9.67 % 16.5 % 20.12 % 20.75 % 21.98 %
KEQU's Overall Ranking # 760 # 438 # 303 # 242 # 244
Seq. Investment Change TTM 10.95 % 14.56 % 4.16 % 4.36 % 4.68 %
Seq. Net Income Change TTM -34.98 % -6.06 % 0.99 % -1.45 % 112.41 %
Net Income (TTM) in Millions 12 18 19 19 19




Return On Investment KEQU's Ranking
Within: No.
Industry # 4
Sector # 87
Overall # 760

Return On Investment Statistics
High Average Low
21.1 %
4.65 %
-15.14 %
(Apr 30 2024)   (Jan 31 2022)







Financial Statements
Kewaunee Scientific's IV. Quarter Investments $ 143 Millions KEQU's Balance sheet
Kewaunee Scientific's IV. Quarter Income $ 5 Millions Quarterly KEQU's Income Statement
KEQU's Income by Division See KEQU's Income by Division


KEQU Annual Return On Investment (Apr 30 2025)
2025
(Apr 30 2024)
2024
(Apr 30 2023)
2023
(Apr 30 2022)
2022
(Apr 30 2021)
2021
Total Investments in Millions 143 95 80 77 55
Y / Y Investment Growth 49.56 % 19.41 % 3.84 % 38.81 % -2.99 %
Net Income in Millions 12 19 1 -6 -4
Y / Y Net Income Growth -39.22 % 1302.28 % - - -
Annual Return On Investment 8.12 % 19.97 % 1.7 % -7.8 % -6.51 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 8.12 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KEQU's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for KEQU's Competitors
Roi for Kewaunee Scientific's Suppliers
Return On Investment for KEQU's Customers

Other Ratios
KEQU's Roa KEQU's Inventory Turnover Ratio KEQU's Growth Rates KEQU's Dividend Statistics
KEQU's Profitability Ratios KEQU's Asset Turnover Ratio KEQU's Dividend Growth
KEQU's Roe KEQU's Valuation Ratios KEQU's Financial Strength Ratios KEQU's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2025, within Healthcare Sector ROI
Halozyme Therapeutics Inc   24.84 %
Siga Technologies Inc  24.80 %
Lipocine Inc   23.82 %
Abbott Laboratories  22.74 %
Eli Lilly And Company  22.61 %
Iradimed Corporation  22.50 %
Lifevantage Corp  22.46 %
Pro dex Inc   21.81 %
Biomx Inc  21.77 %
Merck and Co Inc   21.45 %
Zoetis Inc   21.39 %
Alkermes Plc   21.31 %
Resmed Inc   19.94 %
Chemed Corporation  19.89 %
Corcept Therapeutics Inc  19.81 %
Harmony Biosciences Holdings inc   19.19 %
Mimedx Group Inc   19.17 %
Third Harmonic Bio Inc   19.10 %
Waters Corporation  18.97 %
United Therapeutics Corporation  18.78 %
Stoke Therapeutics Inc   18.27 %
Minerva Neurosciences Inc   17.19 %
Johnson and Johnson  16.51 %
Electromed Inc   16.50 %
Lantheus Holdings Inc   15.68 %
Insulet Corporation  15.36 %
West Pharmaceutical Services Inc   15.32 %
Hca Healthcare Inc   15.32 %
Intuitive Surgical Inc   15.05 %
3m Company  14.85 %


Date modified: 2025-07-10T19:08:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com